Video Event | The Role of Medical Innovation and Patents in Defeating the "Invisible Enemy"

May 2020

Past Event

Video Event | The Role of Medical Innovation and Patents in Defeating the "Invisible Enemy"

Past Event

Hudson Institute, Washington, D.C. Headquarters

May 22, 2020

May 2020

Past Event

1201 Pennsylvania Avenue, N.W., Suite 400
Washington, DC 20004

Speakers:

Adam Mossoff

Senior Fellow, Hudson Institute

Frederick Reinhart

Senior Advisor for Technology Transfer, University of Massachusetts Amherst

Melissa Brand

Assistant General Counsel and Director for Intellectual Property, Biotechnology Innovation Organization

Eric Victory

Vice President for Global Strategic Marketing, Aurinia Pharmaceuticals

**__Please be advised: This event will be premiering at 9:00 a.m. EDT, Friday, May 22. You may view this event on Hudson’s website at or after its premiere time on this event page.__**

COVID-19 has inflicted worldwide economic damage and killed hundreds of thousands of people. However, because of the innovative potential of the modern biopharmaceutical industry, it is unlikely to be a repeat of the Spanish Flu Pandemic of 1918, which killed tens of millions of people around the globe.

Companies like Gilead, Moderna, and many others are investing billions of dollars and thousands of labor hours to create new tests, treatments, and a vaccine to minimize, if not effectively eradicate, the coronavirus.

Join Hudson Institute for a discussion with top industry experts on the role of patents in funding innovative developments; why some policy-makers have proposed restricting or eliminating patent rights on COVID-19 related treatments or vaccines; and how empowering the private-sector is a likely winning strategy in the battle to defeat the "invisible enemy."

October 2026

In-Person Event | Hudson Institute

Anticompetitive and Deceptive Conduct in Healthcare with FTC Chairman Andrew Ferguson

Featured Speakers:

Andrew Ferguson

Harold Furchtgott-Roth

October 2026

In-Person Event | Hudson Institute

Anticompetitive and Deceptive Conduct in Healthcare with FTC Chairman Andrew Ferguson

Join Hudson Institute for a discussion with Federal Trade Commission Chairman Andrew Ferguson and Senior Fellow Harold Furchtgott-Roth.

Featured Speakers:

Andrew Ferguson

Harold Furchtgott-Roth

Learn More

October 2026

In-Person Event | Hudson Institute

Trilateral US-Japan-Taiwan Cooperation on Physical AI

Featured Speakers:

Jeremy Chih-Cheng Chang

Ken Fukuda

Emma Rafaelof

William Chou

October 2026

In-Person Event | Hudson Institute

Trilateral US-Japan-Taiwan Cooperation on Physical AI

Join Hudson Institute for remarks and a panel discussion on how the US, Japan, and Taiwan can collaborate to seize Physical AI’s opportunities.

Featured Speakers:

Jeremy Chih-Cheng Chang

Ken Fukuda

Emma Rafaelof

William Chou

Learn More

October 2026

In-Person Event | Hudson Institute

Landmines, Nuclear Weapons, Deterrence, and Stability on the Korean Peninsula

Featured Speakers:

Patrick M. Cronin

Lieutenant General (Ret.) In-bum Chun

Mira Rapp-Hooper

Ankit Panda

October 2026

In-Person Event | Hudson Institute

Landmines, Nuclear Weapons, Deterrence, and Stability on the Korean Peninsula

Join Hudson Institute Asia-Pacific Security Chair Patrick M. Cronin for an expert panel featuring Lieutenant General (Ret.)In-bum Chun, Dr. Mira Rapp-Hooper, and Ankit Panda.

Featured Speakers:

Patrick M. Cronin

Lieutenant General (Ret.) In-bum Chun

Mira Rapp-Hooper

Ankit Panda

Learn More

October 2026

In-Person Event | Hudson Institute

Outcompeting China Through Technology, Industry, and Allied Power with Senator Dave McCormick

Featured Speakers:

Senator David McCormick

Mike Gallagher

October 2026

In-Person Event | Hudson Institute

Outcompeting China Through Technology, Industry, and Allied Power with Senator Dave McCormick

Join Senator Dave McCormick (R-PA), who recently visited Japan and Korea, and Distinguished Fellow Mike Gallagher for a fireside discussion on United States–China relations, the role of allies and partners in America’s Indo-Pacific strategy, and how the US can harness technology, industrial capacity, and allied strength to prevail in the defining strategic competition of our time.